Your browser doesn't support javascript.
loading
TGF-ß specifies TFH versus TH17 cell fates in murine CD4+ T cells through c-Maf.
Chang, Yinshui; Bach, Luisa; Hasiuk, Marko; Wen, Lifen; Elmzzahi, Tarek; Tsui, Carlson; Gutiérrez-Melo, Nicolás; Steffen, Teresa; Utzschneider, Daniel T; Raj, Timsse; Jost, Paul Jonas; Heink, Sylvia; Cheng, Jingyuan; Burton, Oliver T; Zeiträg, Julia; Alterauge, Dominik; Dahlström, Frank; Becker, Jennifer-Christin; Kastl, Melanie; Symeonidis, Konstantinos; van Uelft, Martina; Becker, Matthias; Reschke, Sarah; Krebs, Stefan; Blum, Helmut; Abdullah, Zeinab; Paeschke, Katrin; Ohnmacht, Caspar; Neumann, Christian; Liston, Adrian; Meissner, Felix; Korn, Thomas; Hasenauer, Jan; Heissmeyer, Vigo; Beyer, Marc; Kallies, Axel; Jeker, Lukas T; Baumjohann, Dirk.
Afiliação
  • Chang Y; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Bach L; Institute for Immunology, Faculty of Medicine, Biomedical Center, LMU Munich, Grosshaderner Str. 9, 82152 Planegg-Martinsried, Germany.
  • Hasiuk M; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Wen L; Department of Biomedicine, Basel University Hospital and University of Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland.
  • Elmzzahi T; Transplantation Immunology and Nephrology, Basel University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland.
  • Tsui C; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.
  • Gutiérrez-Melo N; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.
  • Steffen T; Immunogenomics and Neurodegeneration, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.
  • Utzschneider DT; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.
  • Raj T; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Jost PJ; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Heink S; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.
  • Cheng J; Institute for Immunology, Faculty of Medicine, Biomedical Center, LMU Munich, Grosshaderner Str. 9, 82152 Planegg-Martinsried, Germany.
  • Burton OT; Faculty of Mathematics and Natural Sciences, University of Bonn, Bonn, Germany.
  • Zeiträg J; Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine, 81675 Munich, Germany.
  • Alterauge D; Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Dahlström F; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Becker JC; Institute for Immunology, Faculty of Medicine, Biomedical Center, LMU Munich, Grosshaderner Str. 9, 82152 Planegg-Martinsried, Germany.
  • Kastl M; Institute for Immunology, Faculty of Medicine, Biomedical Center, LMU Munich, Grosshaderner Str. 9, 82152 Planegg-Martinsried, Germany.
  • Symeonidis K; Institute for Immunology, Faculty of Medicine, Biomedical Center, LMU Munich, Grosshaderner Str. 9, 82152 Planegg-Martinsried, Germany.
  • van Uelft M; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Becker M; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Reschke S; Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Krebs S; Institute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Blum H; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Abdullah Z; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.
  • Paeschke K; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.
  • Ohnmacht C; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Feodor-Lynen-Str. 25, 81377 Munich, Germany.
  • Neumann C; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Feodor-Lynen-Str. 25, 81377 Munich, Germany.
  • Liston A; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Feodor-Lynen-Str. 25, 81377 Munich, Germany.
  • Meissner F; Institute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Korn T; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Hasenauer J; Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Heissmeyer V; Center of Allergy and Environment (ZAUM), Technical University and Helmholtz Center Munich, Munich, Germany.
  • Beyer M; Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Kallies A; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Jeker LT; Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Baumjohann D; Department of Systems Immunology and Proteomics, Institute of Innate Immunity, Medical Faculty, University of Bonn, Germany.
Sci Immunol ; 9(93): eadd4818, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38427718
ABSTRACT
T follicular helper (TFH) cells are essential for effective antibody responses, but deciphering the intrinsic wiring of mouse TFH cells has long been hampered by the lack of a reliable protocol for their generation in vitro. We report that transforming growth factor-ß (TGF-ß) induces robust expression of TFH hallmark molecules CXCR5 and Bcl6 in activated mouse CD4+ T cells in vitro. TGF-ß-induced mouse CXCR5+ TFH cells are phenotypically, transcriptionally, and functionally similar to in vivo-generated TFH cells and provide critical help to B cells. The study further reveals that TGF-ß-induced CXCR5 expression is independent of Bcl6 but requires the transcription factor c-Maf. Classical TGF-ß-containing T helper 17 (TH17)-inducing conditions also yield separate CXCR5+ and IL-17A-producing cells, highlighting shared and distinct cell fate trajectories of TFH and TH17 cells. We demonstrate that excess IL-2 in high-density T cell cultures interferes with the TGF-ß-induced TFH cell program, that TFH and TH17 cells share a common developmental stage, and that c-Maf acts as a switch factor for TFH versus TH17 cell fates in TGF-ß-rich environments in vitro and in vivo.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Linfócitos T Auxiliares-Indutores Limite: Animals Idioma: En Revista: Sci Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Linfócitos T Auxiliares-Indutores Limite: Animals Idioma: En Revista: Sci Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha